Fang-Fei Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fang-Fei Wei has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
- Chen Liu
Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, PR China
15 shared publications - Jan A. Staessen
Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
14 shared publications Yugang Dong
Department of Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
11 shared publicationsJiangui He
Department of Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
10 shared publicationsXin He
Department of Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
9 shared publications- Yan Li
Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, National Research Centre for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
9 shared publications
Latest Publications
- 22 June 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (8) , 2329-2339
Comparative prognostic value of non-invasive ventricular-arterial coupling metrics in the general population
Impaired ventricular-arterial coupling (VAC) is associated with adverse health outcomes. However, the predictive values of VAC calculated by different non-invasive methods remain uncertain. We aimed to assess prognostic values of VAC calculated as the ratio between arterial elastance (Ea) and left ventricular end-systolic elastance (Ees) and between carotid-femoral pulse wave velocity (PWV) and global longitudinal strain (GLS). In 3634 Atherosclerosis Risk In Communities study participants (57.4% women; mean age, 75.1 years), Cox proportional hazard models were constructed to determine associations of VAC metrics with heart failure (HF) and all-cause mortality. Risk prediction models were employed to examine prediction improvement of VAC beyond established risk factors. Over approximately 6.3 years (median), 316 participants experienced HF, and 482 died. The hazard ratios of HF related to 1-SD increment in VAC metrics were 1.28 (95% CI, 1.18-1.38; P < 0.001) for Ea/Ees and 1.40 (1.27-1.54; P < 0.001) for PWV/GLS with adjustments applied for potential confounders. PWV/GLS was the only VAC parameter associated with mortality (adjusted HR, 1.18; 1.08-1.28; P < 0.001). PWV/GLS was observed to have stronger associations with all outcomes in individuals aged ≤74 years than those aged >74 years (P for interaction ≤0.034). The addition of VAC maker to the conventional risk factors improved risk prediction for incident HF (P ≤ 0.010) assessed by C statistics, net reclassification improvement, and integrated discrimination improvement for Ea/Ees (0.702, 22.4%, and 1.40%) and for PWV/GLS (0.701, 22.1%, and 1.46%). In the general population, impaired VAC was associated with a higher risk of incident HF and total mortality.
- 22 June 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (8) , 2329-2339
Comparative prognostic value of non-invasive ventricular-arterial coupling metrics in the general population
Impaired ventricular-arterial coupling (VAC) is associated with adverse health outcomes. However, the predictive values of VAC calculated by different non-invasive methods remain uncertain. We aimed to assess prognostic values of VAC calculated as the ratio between arterial elastance (Ea) and left ventricular end-systolic elastance (Ees) and between carotid-femoral pulse wave velocity (PWV) and global longitudinal strain (GLS). In 3634 Atherosclerosis Risk In Communities study participants (57.4% women; mean age, 75.1 years), Cox proportional hazard models were constructed to determine associations of VAC metrics with heart failure (HF) and all-cause mortality. Risk prediction models were employed to examine prediction improvement of VAC beyond established risk factors. Over approximately 6.3 years (median), 316 participants experienced HF, and 482 died. The hazard ratios of HF related to 1-SD increment in VAC metrics were 1.28 (95% CI, 1.18-1.38; P < 0.001) for Ea/Ees and 1.40 (1.27-1.54; P < 0.001) for PWV/GLS with adjustments applied for potential confounders. PWV/GLS was the only VAC parameter associated with mortality (adjusted HR, 1.18; 1.08-1.28; P < 0.001). PWV/GLS was observed to have stronger associations with all outcomes in individuals aged ≤74 years than those aged >74 years (P for interaction ≤0.034). The addition of VAC maker to the conventional risk factors improved risk prediction for incident HF (P ≤ 0.010) assessed by C statistics, net reclassification improvement, and integrated discrimination improvement for Ea/Ees (0.702, 22.4%, and 1.40%) and for PWV/GLS (0.701, 22.1%, and 1.46%). In the general population, impaired VAC was associated with a higher risk of incident HF and total mortality.
- 27 February 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (5) , 1736-1748
Cardiovascular endpoints in relation to the central arterial pressure-time indexes
Multiple articles focused on the central arterial systolic (SPTI) and diastolic (DPTI) pressure-time indexes and the subendocardial viability ratio (SEVR). However, whether these indexes contribute to risk stratification in the general population is unknown. SPTI, DPTI and SEVR were noninvasively measured by the SphygmoCor technology. Incidence rates and standardized (per 1-SD increment) multivariable-adjusted hazard ratios (HRs) for cardiovascular (primary) and cardiac endpoints and stroke were evaluated in the International Database of Central Arterial Properties for Risk Stratification (n = 5099). Model refinement was assessed by the area under the curve (AUC) and the integrated discrimination (IDI) and net reclassification (NRI) improvement. Over 4 years (median), 215 cardiovascular, 133 cardiac endpoints and 79 strokes occurred. For SPTI, fully adjusted HRs were 1.37 (95% CI: 1.18-1.59), 1.35 (1.11-1.64) and 1.33 (1.05-1.69) for the cardiovascular and cardiac endpoints and stroke. The corresponding HRs for DPTI were 1.49 (1.31-1.69), 1.23 (1.02-1.48) and 1.74 (1.46-2.07). For SEVR, none of the HRs reached significance. Analyses with these indexes categorized by quartiles were confirmatory. Analyses stratified by various risk factors did not reveal subgroup differences. For the cardiovascular endpoint, adding SPTI or DPTI to the base model improved the AUC, while adding SPTI or DPTI combined with mean arterial pressure, increased IDI by ~1.7% and NRI by ~17% (P < 0.001 for all). Whereas cardiovascular and cardiac endpoints and stroke were related with the non-invasively measured SPTI and DPTI, SEVR was not.
- 27 February 2026
- Published by Springer Nature in Hypertension Research
- Vol. 49 (5) , 1736-1748
Cardiovascular endpoints in relation to the central arterial pressure-time indexes
Multiple articles focused on the central arterial systolic (SPTI) and diastolic (DPTI) pressure-time indexes and the subendocardial viability ratio (SEVR). However, whether these indexes contribute to risk stratification in the general population is unknown. SPTI, DPTI and SEVR were noninvasively measured by the SphygmoCor technology. Incidence rates and standardized (per 1-SD increment) multivariable-adjusted hazard ratios (HRs) for cardiovascular (primary) and cardiac endpoints and stroke were evaluated in the International Database of Central Arterial Properties for Risk Stratification (n = 5099). Model refinement was assessed by the area under the curve (AUC) and the integrated discrimination (IDI) and net reclassification (NRI) improvement. Over 4 years (median), 215 cardiovascular, 133 cardiac endpoints and 79 strokes occurred. For SPTI, fully adjusted HRs were 1.37 (95% CI: 1.18-1.59), 1.35 (1.11-1.64) and 1.33 (1.05-1.69) for the cardiovascular and cardiac endpoints and stroke. The corresponding HRs for DPTI were 1.49 (1.31-1.69), 1.23 (1.02-1.48) and 1.74 (1.46-2.07). For SEVR, none of the HRs reached significance. Analyses with these indexes categorized by quartiles were confirmatory. Analyses stratified by various risk factors did not reveal subgroup differences. For the cardiovascular endpoint, adding SPTI or DPTI to the base model improved the AUC, while adding SPTI or DPTI combined with mean arterial pressure, increased IDI by ~1.7% and NRI by ~17% (P < 0.001 for all). Whereas cardiovascular and cardiac endpoints and stroke were related with the non-invasively measured SPTI and DPTI, SEVR was not.
- Open Access
- 7 February 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200594
Impact of hypertension on associations of all-cause mortality with admission lipoprotein (a) in acute decompensated heart failure
- 7 February 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200594
Open AccessImpact of hypertension on associations of all-cause mortality with admission lipoprotein (a) in acute decompensated heart failure
- 1 February 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (2)
LV Mass in Children With Extremely Low Birth Weight Is Lower But More Sensitive to Increased Blood Pressure
BACKGROUND: Epidemiological evidence suggests higher rates of heart failure in adults born at an extremely low birth weight (ELBW). Reports on the echocardiographic phenotype in this population are inconsistent and do not consider the effect of modifiable contributors such as blood pressure. METHODS: This study reports on the echocardiographic findings of the PREMATurity as predictor of children's Cardiovascular-renal Health (PREMATCH) study, a prospective case-control study evaluating renal and cardiovascular outcomes in children with ELBW in comparison to term-born controls. Left ventricular (LV) mass was the primary outcome. Data were analyzed with multivariable-adjusted regression models considering anthropometric variables and systolic blood pressure as covariates. RESULTS: Eighty cases (median age, 10.8 years) and 72 controls (median age, 11.4 years) were included. Multivariable-adjusted analyses revealed that the adjusted difference in LV mass in cases versus controls was −8.49 g (CI, −13.78 to −3.20; P =0.002). Sex, height, weight, and body fat percentage were significant covariates. There was a positive interaction between ELBW status and systolic blood pressure ( P interaction =0.039). There was a −6.47 g (CI, −11.7 to 1.28; P =0.016) difference in LV mass between normotensive cases and controls, while the difference disappeared between subjects with increased blood pressure or hypertension. CONCLUSIONS: ELBW children exhibit lower LV mass during childhood in comparison with term-born controls. However, elevations in systolic blood pressure are associated with a steeper increase in LV mass in cases than in controls. Our findings question whether cutoffs for the general population are adequate to evaluate and manage hypertension and LV hypertrophy in children with ELBW.
- 1 February 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (2)
LV Mass in Children With Extremely Low Birth Weight Is Lower But More Sensitive to Increased Blood Pressure
BACKGROUND: Epidemiological evidence suggests higher rates of heart failure in adults born at an extremely low birth weight (ELBW). Reports on the echocardiographic phenotype in this population are inconsistent and do not consider the effect of modifiable contributors such as blood pressure. METHODS: This study reports on the echocardiographic findings of the PREMATurity as predictor of children's Cardiovascular-renal Health (PREMATCH) study, a prospective case-control study evaluating renal and cardiovascular outcomes in children with ELBW in comparison to term-born controls. Left ventricular (LV) mass was the primary outcome. Data were analyzed with multivariable-adjusted regression models considering anthropometric variables and systolic blood pressure as covariates. RESULTS: Eighty cases (median age, 10.8 years) and 72 controls (median age, 11.4 years) were included. Multivariable-adjusted analyses revealed that the adjusted difference in LV mass in cases versus controls was −8.49 g (CI, −13.78 to −3.20; P =0.002). Sex, height, weight, and body fat percentage were significant covariates. There was a positive interaction between ELBW status and systolic blood pressure ( P interaction =0.039). There was a −6.47 g (CI, −11.7 to 1.28; P =0.016) difference in LV mass between normotensive cases and controls, while the difference disappeared between subjects with increased blood pressure or hypertension. CONCLUSIONS: ELBW children exhibit lower LV mass during childhood in comparison with term-born controls. However, elevations in systolic blood pressure are associated with a steeper increase in LV mass in cases than in controls. Our findings question whether cutoffs for the general population are adequate to evaluate and manage hypertension and LV hypertrophy in children with ELBW.
- 5 December 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 144, 106625
Methodological considerations for interpreting the association between central systolic blood pressure and brain health. Author’s reply
- 5 December 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 144, 106625
Methodological considerations for interpreting the association between central systolic blood pressure and brain health. Author’s reply
- Open Access
- 23 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (10) , 102184
Low-Density Lipoprotein Cholesterol Time in Target Range and Clinical Outcomes in the General Population
- 23 September 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (10) , 102184
Open AccessLow-Density Lipoprotein Cholesterol Time in Target Range and Clinical Outcomes in the General Population
- Open Access
- 28 June 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (6)
Myocardial Blood Flow and the Retinal Microvasculature Across the Spectrum From Normal to Failing Hearts
Deficiency of the myocardial microcirculation plays a role in the pathogenesis of heart failure (HF). We aimed to investigate the association of myocardial blood flow (MBF) and the retinal microvasculature with left ventricular (LV) function and its potential mediators. In healthy controls (HCs; n = 48), patients with cardiovascular risk factors (CVRF; n = 49) and patients with compensated HF (CHF; n = 52), we assessed LV diastolic filling pressure (E/e′), LV ejection fraction (LVEF), and global longitudinal strain (GLS) associated with MBF and the retinal arteriole‐to‐venule ratio (AVR), using multivariable regression models, while considering their direct contributions to LV function and the indirect contributions running via NT‐proBNP. Compared with HC, CHF had lower MBF and smaller AVR (p ≤ 0.002). In all participants, smaller AVR was associated with higher E/e′, lower LVEF, and lower GLS (p ≤ 0.010). Per 1 dB × dB/s MBF reduction, E/e′ increased by 0.09, whereas LVEF and GLS decreased by 0.46% and 0.14%, respectively (p < 0.001). The indirect contributions running via NT‐proBNP were all significant (p < 0.001) for MBF and for AVR related to GLS (p = 0.044) with mediation proportions of ≥29%. Across subgroups, these associations were directionally similar but lost significance given the lower sample size. Furthermore, across the spectrum of LV function, estimates of the associations of MBF with E/e′ and AVR with GLS showed a decreasing versus increasing trend (p ≤ 0.034). MBF and retinal microvasculature were associated with LV function and counterbalance the impaired LV function in CHF. NT‐proBNP, the natural vasodilating and natriuretic hormone, contributes close to 30% of the maintenance of LV function.
- 28 June 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (6)
Open AccessMyocardial Blood Flow and the Retinal Microvasculature Across the Spectrum From Normal to Failing Hearts
Deficiency of the myocardial microcirculation plays a role in the pathogenesis of heart failure (HF). We aimed to investigate the association of myocardial blood flow (MBF) and the retinal microvasculature with left ventricular (LV) function and its potential mediators. In healthy controls (HCs; n = 48), patients with cardiovascular risk factors (CVRF; n = 49) and patients with compensated HF (CHF; n = 52), we assessed LV diastolic filling pressure (E/e′), LV ejection fraction (LVEF), and global longitudinal strain (GLS) associated with MBF and the retinal arteriole‐to‐venule ratio (AVR), using multivariable regression models, while considering their direct contributions to LV function and the indirect contributions running via NT‐proBNP. Compared with HC, CHF had lower MBF and smaller AVR (p ≤ 0.002). In all participants, smaller AVR was associated with higher E/e′, lower LVEF, and lower GLS (p ≤ 0.010). Per 1 dB × dB/s MBF reduction, E/e′ increased by 0.09, whereas LVEF and GLS decreased by 0.46% and 0.14%, respectively (p < 0.001). The indirect contributions running via NT‐proBNP were all significant (p < 0.001) for MBF and for AVR related to GLS (p = 0.044) with mediation proportions of ≥29%. Across subgroups, these associations were directionally similar but lost significance given the lower sample size. Furthermore, across the spectrum of LV function, estimates of the associations of MBF with E/e′ and AVR with GLS showed a decreasing versus increasing trend (p ≤ 0.034). MBF and retinal microvasculature were associated with LV function and counterbalance the impaired LV function in CHF. NT‐proBNP, the natural vasodilating and natriuretic hormone, contributes close to 30% of the maintenance of LV function.
- Open Access
- 1 May 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 136, 101-106
Cerebral small vessel disease and cognitive dysfunction in relation to central systolic blood pressure
- 1 May 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 136, 101-106
Open AccessCerebral small vessel disease and cognitive dysfunction in relation to central systolic blood pressure
- Open Access
- 17 January 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (1) , e14962
Association of Total Mortality and Cardiovascular Endpoints With the Timing of the First and Second Systolic Peak of the Aortic Pulse Wave
Prognostic significance of the timing in the cardiac cycle of the first (TP1) and second (TP2) systolic peak of the central aortic pulse wave is ill‐defined. Incidence rates and standardized multivariable‐adjusted hazard ratios (HRs) of adverse health outcomes associated with TP1 and TP2, estimated by the SphygmoCor software, were assessed in the International Database of Central Arterial Properties for Risk Stratification (IDCARS) (n = 5529). Model refinement was assessed by the integrated discrimination (ID) and net reclassification (NR) improvement. Over 4.1 years (median), 201 participants died and 248 and 159 patients experienced cardiovascular or cardiac endpoints. Mean TP1 and TP2, standardized for cohort, sex, age, and heart rate, were 103 and 228 ms. Shorter TP1 and TP2 were associated with higher mortality and shorter TP1 with a higher risk of cardiovascular and cardiac endpoints (trend p ≤ 0.004). The HRs relating total mortality and cardiovascular endpoints to TP2 were 0.82 (95% confidence interval [CI]: 0.72–0.94) and 0.87 (0.77–0.98), respectively. The HR relating cardiac endpoints to TP1 was 0.81 (0.68–0.97). For total mortality and cardiovascular endpoints in relation to TP2, NRI was significant (p ≤ 0.010), but not for cardiac endpoints in relation to TP1. Integrated discrimination improvement (IDI) was not significant for any endpoint. The HRs relating total mortality to TP2 were smaller (p ≤ 0.026) in women than men (0.67 vs. 0.95) and in older (≥ 60 years) versus younger (< 60 years) participants (0.80 vs. 0.88). Our study adds to the evidence supporting risk stratification based on aortic pulse analysis by showing that TP2 and TP1 carry prognostic information.
- 17 January 2025
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 27 (1) , e14962
Open AccessAssociation of Total Mortality and Cardiovascular Endpoints With the Timing of the First and Second Systolic Peak of the Aortic Pulse Wave
Prognostic significance of the timing in the cardiac cycle of the first (TP1) and second (TP2) systolic peak of the central aortic pulse wave is ill‐defined. Incidence rates and standardized multivariable‐adjusted hazard ratios (HRs) of adverse health outcomes associated with TP1 and TP2, estimated by the SphygmoCor software, were assessed in the International Database of Central Arterial Properties for Risk Stratification (IDCARS) (n = 5529). Model refinement was assessed by the integrated discrimination (ID) and net reclassification (NR) improvement. Over 4.1 years (median), 201 participants died and 248 and 159 patients experienced cardiovascular or cardiac endpoints. Mean TP1 and TP2, standardized for cohort, sex, age, and heart rate, were 103 and 228 ms. Shorter TP1 and TP2 were associated with higher mortality and shorter TP1 with a higher risk of cardiovascular and cardiac endpoints (trend p ≤ 0.004). The HRs relating total mortality and cardiovascular endpoints to TP2 were 0.82 (95% confidence interval [CI]: 0.72–0.94) and 0.87 (0.77–0.98), respectively. The HR relating cardiac endpoints to TP1 was 0.81 (0.68–0.97). For total mortality and cardiovascular endpoints in relation to TP2, NRI was significant (p ≤ 0.010), but not for cardiac endpoints in relation to TP1. Integrated discrimination improvement (IDI) was not significant for any endpoint. The HRs relating total mortality to TP2 were smaller (p ≤ 0.026) in women than men (0.67 vs. 0.95) and in older (≥ 60 years) versus younger (< 60 years) participants (0.80 vs. 0.88). Our study adds to the evidence supporting risk stratification based on aortic pulse analysis by showing that TP2 and TP1 carry prognostic information.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2025 (1) , 8858333
Cardiovascular Outcomes and Variability in Plasma Lipid Levels Across Body Mass Index Categories: The ARIC Study
The aim of this study was to investigate associations of cardiovascular outcomes with lipid variability across body mass index categories. We identified 6689 participants (57.1% women) enrolled in the Atherosclerosis Risk In Communities (ARICs) study who had ≥ 3 measurements of total cholesterol (TC) and low‐density lipoprotein cholesterol (LDL‐C). Cox regression models were used to compute hazard ratios (HRs)‐associated heart failure (HF), myocardial infarction (MI), and mortality with 1‐SD increase in lipid variability captured by SD and variability independent of the mean (VIM). We also assessed whether adding lipid variability would improve the cardiovascular risk prediction beyond the conventional risk factors. Among 2130 (31.8%) obese patients, 1907 (89.5%) had obesity classes I and II and 223 (10.5%) had obesity class III. In multivariable‐adjusted analyses, TC and LDL‐C variabilities were significantly ( p ≤ 0.047) associated with HF in overweight (HRs ranging from 1.10 to 1.17), obesity classes I and II (1.11–1.14), and obesity class III (1.21–1.39). Higher TC and LDL‐C variabilities conferred higher risk of MI and mortality in obesity classes I and II ( p ≤ 0.007). Adding TC–VIM and LDL‐C–VIM rather than the lipid level to a conventional risk model significantly improved risk prediction of HF with net reclassification improvement amounting to 8.95% for TC–VIM ( p = 0.006) and 8.09% for LDL‐C–VIM ( p = 0.012). Elevated TC and LDL‐C variabilities were associated with the increased risk of cardiovascular outcomes, particularly in obesity. Our observations highlight the importance of lipid variability in obesity‐associated dyslipidemia.
- 1 January 2025
- Published by Wiley in Journal of Nutrition and Metabolism
- Vol. 2025 (1) , 8858333
Open AccessCardiovascular Outcomes and Variability in Plasma Lipid Levels Across Body Mass Index Categories: The ARIC Study
The aim of this study was to investigate associations of cardiovascular outcomes with lipid variability across body mass index categories. We identified 6689 participants (57.1% women) enrolled in the Atherosclerosis Risk In Communities (ARICs) study who had ≥ 3 measurements of total cholesterol (TC) and low‐density lipoprotein cholesterol (LDL‐C). Cox regression models were used to compute hazard ratios (HRs)‐associated heart failure (HF), myocardial infarction (MI), and mortality with 1‐SD increase in lipid variability captured by SD and variability independent of the mean (VIM). We also assessed whether adding lipid variability would improve the cardiovascular risk prediction beyond the conventional risk factors. Among 2130 (31.8%) obese patients, 1907 (89.5%) had obesity classes I and II and 223 (10.5%) had obesity class III. In multivariable‐adjusted analyses, TC and LDL‐C variabilities were significantly ( p ≤ 0.047) associated with HF in overweight (HRs ranging from 1.10 to 1.17), obesity classes I and II (1.11–1.14), and obesity class III (1.21–1.39). Higher TC and LDL‐C variabilities conferred higher risk of MI and mortality in obesity classes I and II ( p ≤ 0.007). Adding TC–VIM and LDL‐C–VIM rather than the lipid level to a conventional risk model significantly improved risk prediction of HF with net reclassification improvement amounting to 8.95% for TC–VIM ( p = 0.006) and 8.09% for LDL‐C–VIM ( p = 0.012). Elevated TC and LDL‐C variabilities were associated with the increased risk of cardiovascular outcomes, particularly in obesity. Our observations highlight the importance of lipid variability in obesity‐associated dyslipidemia.